PINE vs. CLIN, EVR, BGSC, PRSR, GROW, DX, ARR, SOHO, MGP, and ADVT
Should you be buying Pinewood Technologies Group stock or one of its competitors? The main competitors of Pinewood Technologies Group include Clinigen Group (CLIN), EVRAZ (EVR), BMO Global Smaller Companies (BGSC), Prs Reit (PRSR), Molten Ventures (GROW), DX (Group) (DX), Aurora Investment Trust (ARR), Triple Point Social Housing REIT (SOHO), Medica Group (MGP), and AdvancedAdvT (ADVT). These companies are all part of the "trading" industry.
Pinewood Technologies Group vs.
Pinewood Technologies Group (LON:PINE) and Clinigen Group (LON:CLIN) are both small-cap consumer cyclical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk.
Pinewood Technologies Group has a net margin of 167.76% compared to Clinigen Group's net margin of 0.00%. Pinewood Technologies Group's return on equity of 11.83% beat Clinigen Group's return on equity.
80.8% of Pinewood Technologies Group shares are held by institutional investors. 30.4% of Pinewood Technologies Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Pinewood Technologies Group has higher earnings, but lower revenue than Clinigen Group. Clinigen Group is trading at a lower price-to-earnings ratio than Pinewood Technologies Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, Pinewood Technologies Group had 1 more articles in the media than Clinigen Group. MarketBeat recorded 1 mentions for Pinewood Technologies Group and 0 mentions for Clinigen Group. Pinewood Technologies Group's average media sentiment score of 0.00 equaled Clinigen Group'saverage media sentiment score.
Clinigen Group received 428 more outperform votes than Pinewood Technologies Group when rated by MarketBeat users. However, 100.00% of users gave Pinewood Technologies Group an outperform vote while only 87.40% of users gave Clinigen Group an outperform vote.
Pinewood Technologies Group presently has a consensus target price of GBX 590, indicating a potential upside of 55.67%. Given Pinewood Technologies Group's stronger consensus rating and higher possible upside, equities analysts clearly believe Pinewood Technologies Group is more favorable than Clinigen Group.
Summary
Pinewood Technologies Group beats Clinigen Group on 11 of the 14 factors compared between the two stocks.
Get Pinewood Technologies Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PINE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Pinewood Technologies Group Competitors List
Related Companies and Tools
This page (LON:PINE) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy PINE Stock Free PINE Stock Alerts